enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Regeneron Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Regeneron_Pharmaceuticals

   Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...

3. Biotech company Regeneron buys Avon site in Rockland ... - AOL

   www.aol.com/biotech-company-regeneron-buys-avon...

   Regeneron will also get a tax break on about $50 million of the renovation costs at the site, with exemptions of up to about $4.19 million in state and local sales taxes, according to IDA documents.

4. Regeneron beats quarterly results on strong demand for ... - AOL

   www.aol.com/news/regeneron-beats-quarterly...

   Regeneron reported an adjusted profit of $11.56 per share on total revenue of $3.55 billion for the quarter, above analysts' estimates of $10.61 per share and $3.38 billion, according to LSEG data.

5. Regeneron's Eylea could return to growth after nod to high ...

   www.aol.com/news/regenerons-eylea-could-return...

   Shares of Regeneron rose 1.7% to $826.4 in early trading. A longer dosing gap for the drug could help Regeneron take on rival Roche's Vabysmo and also help soften the blow from incoming cheaper ...

6. Regeneron Named to Dow Jones Sustainability World Index for ...

   lite.aol.com/tech/story/0022/20241216/9319964.htm

   Regeneron is proud to be included in the Dow Jones Sustainability World Index and the Civic 50 list of the most “community-minded” companies in the U.S. Throughout the year, Regeneron empowers and supports employees to give back through our volunteering, pro bono and matching gift programs.

7. George Yancopoulos - Wikipedia

   en.wikipedia.org/wiki/George_Yancopoulos

   In 2014, Yancopoulos led the launch of the Regeneron Genetics Center, a major initiative in human genetic research that has sequenced exomes from over 1,000,000 people as of February 2020. [23] [24] Forbes magazine states Yancopoulos' financial stake in Regeneron has made him a billionaire. He is the first research and development chief in the ...

8. US FDA approves two biosimilars for blockbuster eye drug Eylea

   www.aol.com/news/us-fda-approves-two-biosimilars...

   Regeneron has filed lawsuits against companies such as Amgen and Biocon, which are seeking to bring Eylea biosimilars to the U.S. market.Regeneron recorded U.S. sales of $5.72 billion from its ...

9. Trevogrumab - Wikipedia

   en.wikipedia.org/wiki/Trevogrumab

   This monoclonal antibody –related article is a stub. You can help Wikipedia by expanding it.